Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Annual Report · 10-K

Accolade, Inc.

Annual Report

Filed Apr 26, 2024Accepted Apr 25, 2024, 1:43 PM EDTCIK 1481646Accession 0001481646-24-000020
Share

Company context

Accolade (Nasdaq: ACCD) is a Personalized Healthcare company that provides millions of people and their families with exceptional healthcare experiences so they can live their healthiest lives. Accolade’s employer, health plan, and consumer solutions combine virtual primary care and mental health, expert medical opinion, and best-in-class care navigation. These offerings are built on a platform that is engineered to care through predictive engagement of population health needs, proactive care that improves outcomes and cost savings, and addressing barriers to access and continuity of care. Accolade consistently receives consumer satisfaction ratings of over 90%. For more information, visit accolade.com. Follow us on LinkedIn, X, Instagram, and Facebook.

Recent company filings

  1. SCHEDULE 13G/A - filed by ARK Investment Management LLC regarding Accolade, Inc.May 14, 2025
  2. 15-12G filingApr 18, 2025
  3. SCHEDULE 13D/A - filed by Magnetar Financial LLC regarding Accolade, Inc.Apr 10, 2025
  4. 25-NSE - filed by Nasdaq Stock Market LLC regarding Accolade, Inc.Apr 8, 2025
  5. S-8 POS filingApr 8, 2025

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗